COHANCECohance Lifesciences Limited
Cohance Lifesciences appoints Abhimanyu Ojha as Chief Financial Officer from 12 Oct 2026
- Management change
- Pharma
Cohance Lifesciences Limited has told the exchanges on 9 Oct 2026 that Mr. Abhimanyu Ojha will join as Chief Financial Officer with effect from 12 Oct 2026. The disclosure was made under Regulation 30 of the SEBI listing rules, which covers changes in key managerial personnel.
Inference
A new CFO takes over the finance function from 12 Oct 2026. The part of the filing reviewed here does not say who held the role before, or give his remuneration or notice terms, so the context for the change is not stated.
Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
